Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2

Kiran Shehzadi, Afsheen Saba, Mingjia Yu*, Jianhua Liang*

*此作品的通讯作者

科研成果: 期刊稿件文献综述同行评审

10 引用 (Scopus)

指纹

探究 'Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science